Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by FullReversalon Mar 20, 2016 1:33pm
156 Views
Post# 24680912

RE:Oversold!

RE:Oversold!Humm... coalbet,  you sound like a buddy of mine.... My buddy the trader says the exact same thing... Oversold!

But your profile say 2014 and "novice"?  Humm....

Is that novice trading, investing or bullboarding???

Disclaimer.  Just watching VRX at the moment.  I work with a small team of investors that look at short attacks and profit from them.    I'm more interested in a side casualty right now.  Just "observing" VRX....

coalbet wrote:

In trading on Tuesday, shares of Valeant Pharmaceuticals International Inc (NYSE: VRX) entered into oversold territory, hitting an RSI reading of 26.1, after changing hands as low as $37.24 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 63.1. A bullish investor could look at VRX’s 26.1 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of VRX shares:

Valeant Pharmaceuticals International Inc 1 Year Performance Chart

 

Looking at the chart above, VRX’s low point in its 52 week range is $37.24 per share, with $263.81 as the 52 week high point — that compares with a last trade of $38.74. Find out what 9 other oversold stocks you need to know about »

VRX makes up 2.22% of the Pharmaceutical ETF (AMEX: PPH)



<< Previous
Bullboard Posts
Next >>